Thrombosis Canada/LinkedIn
Dec 6, 2025, 06:25
Dr. Jeff Weitz Unpacks the Latest ROXI-VTE Trials
Thrombosis Canada shared a new post on LinkedIn:
“New episode!
We sat down with Dr. Jeff Weitz to unpack the latest ROXI-VTE trials and what the data could mean for the future of thrombosis prevention.
If you manage patients at risk of VTE, don’t miss this conversation—full of clinical insights, context, and what’s coming next.
Episode goes live across all platforms within 24 hours, but if you can wait, listen to it here.
Title: ROXI-VTE Trials Explained: Dr. Jeff Weitz on Next-Generation Thrombosis Prevention”
Get the latest with Hemostasis Today.
-
Mar 15, 2026, 15:55Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 2
-
Mar 15, 2026, 14:09Abdul Mannan: A Red Eye, a Blood Clot, and Ibrutinib – The Clinical Tightrope
-
Mar 15, 2026, 14:02Denise M: Precision Hemostasis in Patient Blood Management
-
Mar 15, 2026, 13:57Abdulrahman Nasiri: D14 Bone Marrow Biopsy in AML Induction in the Era of Targeted Therapies
-
Mar 15, 2026, 13:52Valentin Ortiz-Maldonado: High-Impact Innovation in CAR-T Therapy Can Emerge From Academic Programmes
-
Mar 15, 2026, 13:45Tareq Abadl: Has Anyone Here Ever Taken an ALP Test Before?
-
Mar 14, 2026, 21:30Ayman Elbadawi: Why Does Stent Thrombosis Still Occur? Insights from the NCDR Data
-
Mar 14, 2026, 20:03Edward Adomako: Recognizing Thrombotic Thrombocytopenic Purpura as A Life-Threatening Emergency
-
Mar 14, 2026, 19:28Vishnu Priya Pulipati: Statins Beyond Cholesterol for Plaque Biology and Cardiovascular Risk Reduction